Table 1. TNBC patient characteristics.
| Characteristic | Median (Range) |
|---|---|
| Age at Diagnosis (Years) (n=209) | 57 (30-91) |
| Follow-Up (Months) | |
| Recurrence Free Survival (n=199) | 38 (1-186) |
| Metastasis Free Survival (n=200) | 40 (1-186) |
| Breast Cancer Specific Survival (n=200) | 46 (1-186) |
| N (%) | |
| Tumor Grade | |
| Grade 2 | 27 (13%) |
| Grade 3 | 181 (87%) |
| Unknown | 1 |
| Histological Type | |
| Ductal | 171 (82%) |
| Lobular | 9 (4%) |
| Metaplastic | 11 (5%) |
| Mixed ductal | 2 (1%) |
| Papillary | 1 (<0.5%) |
| Medullary | 7 (3%) |
| Apocrine | 6 (3%) |
| Micropapillary | 1 (<0.5%) |
| Unknown | 1 (<0.5%) |
| Neoadjuvant Therapy | |
| No | 183 (88%) |
| Yes | 26 (12%) |
| iNOS Levels | |
| Negative | 28 (13%) |
| Weak | 83 (40%) |
| Moderate | 62 (30%) |
| Strong | 36 (17%) |
| Disease Free Survival* | |
| No recurrence | 140 (70%) |
| Recurrence | 59 (30%) |
| Metastasis Free Survival* | |
| No distant metastasis | 154 (77%) |
| Distant Metastasis | 46 (23%) |
| Breast Cancer Specific Survival** | |
| Alive | 151 (75%) |
| Deceased | 49 (25%) |
*9 patients excluded due to distant metastasis at diagnosis, and 1 treated in another country and lost to follow-up.
**9 patients excluded due to death from other causes.